![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 17, Issue 1, 1-13, January 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Essay
Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Submitted September 1, 2005;
Accepted October 21, 2005
Monitoring Editor: Gerard Evan
A standard for bioregulatory network diagrams is urgently needed in the same way that circuit diagrams are needed in electronics. Several graphical notations have been proposed, but none has become standard. We have prepared many detailed bioregulatory network diagrams using the molecular interaction map (MIM) notation, and we now feel confident that it is suitable as a standard. Here, we describe the MIM notation formally and discuss its merits relative to alternative proposals. We show by simple examples how to denote all of the molecular interactions commonly found in bioregulatory networks. There are two forms of MIM diagrams. "Heuristic" MIMs present the repertoire of interactions possible for molecules that are colocalized in time and place. "Explicit" MIMs define particular models (derived from heuristic MIMs) for computer simulation. We show also how pathways or processes can be highlighted on a canonical heuristic MIM. Drawing a MIM diagram, adhering to the rules of notation, imposes a logical discipline that sharpens one's understanding of the structure and function of a network.
Address correspondence to: Kurt W. Kohn (kohnk{at}dc37a.nci.nih.gov).
This article has been cited by other articles:
|
|
 |
|
  M. Tozluoglu, E. Karaca, T. Haliloglu, and R. Nussinov Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis Nucleic Acids Res., July 26, 2008; (2008) gkn481v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Hu, E. S. Snitkin, and C. DeLisi VisANT: an integrative framework for networks in systems biology Brief Bioinform, July 1, 2008; 9(4): 317 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Kohn, M. I. Aladjem, J. N. Weinstein, and Y. Pommier Chromatin Challenges during DNA Replication: A Systems Representation Mol. Biol. Cell, January 1, 2008; 19(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kurata, K. Inoue, K. Maeda, K. Masaki, Y. Shimokawa, and Q. Zhao Extended CADLIVE: a novel graphical notation for design of biochemical network maps and computational pathway analysis Nucleic Acids Res., November 29, 2007; 35(20): e134 - e134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Suderman and M. Hallett Tools for visually exploring biological networks Bioinformatics, October 15, 2007; 23(20): 2651 - 2659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Paveliev, M. Lume, A. Velthut, M. Phillips, U. Arumae, and M. Saarma Neurotrophic factors switch between two signaling pathways that trigger axonal growth J. Cell Sci., August 1, 2007; 120(15): 2507 - 2516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ng, B. Bursteinas, Q. Gao, E. Mollison, and M. Zvelebil Resources for integrative systems biology: from data through databases to networks and dynamic system models Brief Bioinform, December 1, 2006; 7(4): 318 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Weinstein Spotlight on molecular profiling: "Integromic" analysis of the NCI-60 cancer cell lines Mol. Cancer Ther., November 1, 2006; 5(11): 2601 - 2605. [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Hlavacek, J. R. Faeder, M. L. Blinov, R. G. Posner, M. Hucka, and W. Fontana Rules for Modeling Signal-Transduction Systems Sci. Signal., July 18, 2006; 2006(344): re6 - re6. [Abstract] [Full Text] [PDF]
|
|
